Yumanity Therapeutics to Present at the Jefferies 2019 Global Healthcare Conference
CAMBRIDGE, Mass.--(BUSINESS WIRE)--May 23, 2019--
Yumanity Therapeutics, a company focused on discovering transformative therapies to treat neurodegenerative diseases, today announced that Tony Coles, M.D., chairman and chief executive officer, will present at the Jefferies 2019 Global Healthcare Conference on Wednesday, June 5 at 2:30 p.m. EDT. The conference is being held at the Grand Hyatt in New York City. Yumanity Therapeutics’ presentation will take place in the Imperial conference room.
About Yumanity Therapeutics
Yumanity Therapeutics is transforming drug discovery for neurodegenerative diseases caused by protein misfolding. Formed in 2014 by renowned biotech industry leader, Tony Coles, M.D., and protein folding science pioneer, Susan Lindquist, Ph.D., the company is focused on discovering disease-modifying therapies for patients with Parkinson’s disease, Alzheimer’s, and amyotrophic lateral sclerosis (ALS). Leveraging its discovery engine, Yumanity Therapeutics’ innovative new approach to drug discovery and development concentrates on reversing the cellular phenotypes and disease pathologies caused by protein misfolding. For more information, please visit yumanity.com.
View source version on businesswire.com:https://www.businesswire.com/news/home/20190523005122/en/
CONTACT: W2O pure
KEYWORD: UNITED STATES NORTH AMERICA MASSACHUSETTS NEW YORK
INDUSTRY KEYWORD: HEALTH BIOTECHNOLOGY PHARMACEUTICAL GENERAL HEALTH
SOURCE: Yumanity Therapeutics
Copyright Business Wire 2019.
PUB: 05/23/2019 08:00 AM/DISC: 05/23/2019 08:01 AM